Advertisement
U.S. Markets open in 4 hrs 50 mins

Eton Pharmaceuticals, Inc. (ETON)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Visitors trend2W10W9M
8.44+0.09 (+1.08%)
At close: 04:00PM EDT
8.40 -0.04 (-0.47%)
After hours: 04:20PM EDT
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
31,381
31,642
21,251
21,832
39
Cost of Revenue
12,715
10,581
6,933
2,827
436
Gross Profit
18,666
21,061
14,318
19,005
-397
Operating Expense
24,942
22,253
22,578
20,500
26,714
Operating Income
-6,276
-1,192
-8,260
-1,495
-27,111
Net Non Operating Interest Income Expense
690
503
-761
-1,006
-859
Other Income Expense
-
-
-
546
-
Pretax Income
-6,386
-689
-9,021
-1,955
-27,970
Tax Provision
301
247
0
0
0
Net Income Common Stockholders
-6,687
-936
-9,021
-1,955
-27,970
Diluted NI Available to Com Stockholders
-6,687
-936
-9,021
-1,955
-27,970
Basic EPS
0.09
-0.04
-0.36
-0.08
-1.33
Diluted EPS
0.09
-0.04
-0.36
-0.08
-1.33
Basic Average Shares
25,556
25,645
25,146
25,207
21,010
Diluted Average Shares
25,848
25,645
25,146
25,207
21,010
Total Operating Income as Reported
-6,276
-1,192
-8,260
-1,495
-27,111
Total Expenses
37,657
32,834
29,511
23,327
27,150
Net Income from Continuing & Discontinued Operation
-6,687
-936
-9,021
-1,955
-27,970
Normalized Income
-6,687
-936
-9,021
-2,501
-27,970
Net Interest Income
690
503
-761
-1,006
-859
EBIT
-7,076
-1,192
-8,260
-1,495
-27,111
EBITDA
-6,047
-291
-6,486
-1,033
-26,460
Reconciled Cost of Revenue
12,715
10,581
6,933
2,827
436
Reconciled Depreciation
1,029
901
1,774
462
651
Net Income from Continuing Operation Net Minority Interest
-6,687
-936
-9,021
-1,955
-27,970
Total Unusual Items Excluding Goodwill
0
0
0
546
0
Total Unusual Items
0
0
0
546
0
Normalized EBITDA
-6,047
-291
-6,486
-1,579
-26,460
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0